Go Pro

XOMA (XOMAO) Competitors

XOMA logo
$25.00 0.00 (0.00%)
As of 08/7/2026

XOMAO vs. ALVOW, APLMW, ARAV, BIAFW, and BIVIW

Should you buy XOMA stock or one of its competitors? MarketBeat compares XOMA with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with XOMA include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and BioVie (BIVIW). These companies are all part of the "biotechnology" industry.

How does XOMA compare to Alvotech?

XOMA (NASDAQ:XOMAO) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

In the previous week, XOMA's average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
XOMA Neutral
Alvotech Neutral

Company Net Margins Return on Equity Return on Assets
XOMAN/A N/A N/A
Alvotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
XOMA$7.65MN/AN/AN/AN/A
Alvotech$559.42MN/AN/AN/AN/A

Summary

Alvotech beats XOMA on 1 of the 1 factors compared between the two stocks.

How does XOMA compare to Apollomics?

XOMA (NASDAQ:XOMAO) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk.

Company Net Margins Return on Equity Return on Assets
XOMAN/A N/A N/A
Apollomics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
XOMA$7.65MN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

In the previous week, XOMA's average media sentiment score of 0.00 equaled Apollomics'average media sentiment score.

Company Overall Sentiment
XOMA Neutral
Apollomics Neutral

Summary

Apollomics beats XOMA on 1 of the 1 factors compared between the two stocks.

How does XOMA compare to Aravive?

Aravive (NASDAQ:ARAV) and XOMA (NASDAQ:XOMAO) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership.

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
XOMA N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
XOMA$7.65MN/AN/AN/AN/A

In the previous week, Aravive's average media sentiment score of 0.00 equaled XOMA'saverage media sentiment score.

Company Overall Sentiment
Aravive Neutral
XOMA Neutral

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Aravive beats XOMA on 2 of the 3 factors compared between the two stocks.

How does XOMA compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAFW) and XOMA (NASDAQ:XOMAO) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

In the previous week, bioAffinity Technologies' average media sentiment score of 1.02 beat XOMA's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the media.

Company Overall Sentiment
bioAffinity Technologies Positive
XOMA Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.61MN/AN/AN/AN/A
XOMA$7.65MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
bioAffinity TechnologiesN/A N/A N/A
XOMA N/A N/A N/A

Summary

bioAffinity Technologies and XOMA tied by winning 1 of the 2 factors compared between the two stocks.

How does XOMA compare to BioVie?

BioVie (NASDAQ:BIVIW) and XOMA (NASDAQ:XOMAO) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

In the previous week, BioVie's average media sentiment score of 0.00 equaled XOMA'saverage media sentiment score.

Company Overall Sentiment
BioVie Neutral
XOMA Neutral

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
XOMA N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
XOMA$7.65MN/AN/AN/AN/A

Summary

XOMA beats BioVie on 1 of the 1 factors compared between the two stocks.

Get XOMA News Delivered to You Automatically

Sign up to receive the latest news and ratings for XOMAO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XOMAO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XOMAO vs. The Competition

MetricXOMABiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$3.71B$7.03B$12.96B
Dividend Yield9.00%3.76%2.58%10.20%
P/E RatioN/A9.06269.9124.87
Price / SalesN/A1,278.42654.69108.21
Price / CashN/A44.9528.8937.44
Price / BookN/A17.9711.406.45
Net IncomeN/A-$13.25M$3.45B$347.50M
7 Day PerformanceN/A5.58%3.66%3.77%
1 Month Performance0.08%-1.60%-0.49%-0.40%
1 Year Performance-1.50%61.32%77.51%23.55%

XOMA Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XOMAO
XOMA
N/A$25.00
flat
N/AN/A$0.00$7.65MN/A10
ALVOW
Alvotech
N/A$0.15
flat
N/AN/A$0.00$559.42MN/A4
APLMW
Apollomics
N/A$0.01
-12.0%
N/A-28.1%$0.00$8.50MN/A59
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
BIAFW
bioAffinity Technologies
N/A$0.09
+7.4%
N/A-23.6%$0.00$5.61MN/A10

Related Companies and Tools


This page (NASDAQ:XOMAO) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners